ScoutQuest5 Nov 2026
Concord Drugs538965Board meeting scheduled

Board Meeting on 12 November 2026 to Approve September Quarter Results

Concord Drugs' Board is scheduled to meet on Thursday, 12 November 2026 to consider and approve the Un-audited (Standalone & Consolidated) financial results for the quarter ended 30 September 2026.

By ScoutQuest · · 2 min read

Board Meeting Date
Thursday, 12 November 2026
Results Period
Un-audited (Standalone & Consolidated) financial results for the quarter ended 30 September 2026
Trading Window Closure
closed for all designated persons and their immediate relatives, and will remain closed till 48 hours after the results are declared

Concord Drugs has told the exchange that a meeting of its Board of Directors is scheduled for Thursday, 12 November 2026 at the registered office of the company.

The agenda

Trading window

What a retail investor can take away

What this update is not

More numbers
  • Trading window closure after results declaration48 hours
Source: BSE · 5 Nov 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev